Active drug repurposing opportunities
discovered using our AI agents
| Therapeutic area | Preclinical | Phase 1 | Phase 2 | Phase 3 |
|---|---|---|---|---|
| Rare neurodegenerative disorder |
Current stage: Preclinical | — | — | — |
| Rare neurovascular disorder |
Current stage: Preclinical | — | — | — |